FDA Seeks Risk-Based Inspection Program

November 2, 2003
Jill Wechsler
Pharmaceutical Technology

Volume 27, Issue 11

FDA's new policies intend to make GMP inspections more efficient and apply to stricter rules to high-risk products and processes.